What Know About This Fund Exit From Champion Homes Explained
When a fund sells a big stake in Champion Homes, it can reveal more about market sentiment than a quarterly report. T...
Fund Activity
Explore four Fund Activity articles that summarize recent capital moves, new fund bets, and biotech deals. This page helps you spot trends that affect your investments.
19 articles
What Know About This Fund’s Porch Group Purchase: Deep Dive
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
This Biotech 60%. Healthcare Stocks See Fresh $11M Bet
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
What This Fund's Million Signal Could Shape Investing
A prominent fund dumped its monday.com stake in a move that coincided with a steep stock decline. This article breaks...
What Know About This Fund’s AI Stock Sale Now Up 37%
A major fund recently disclosed a sizable sale of an AI marketing stock, a move that coincides with a 37% surge in th...
Oceaneering Stock 105% Year: Big Bet on Growth Strategies
Oceaneering International has staged a striking rally, with a fund-backed bet signaling confidence in continued growt...
What Know About This Fund's Stagwell Buy After Client Wins
A leading investment fund recently opened a sizable stake in STGW after marquee client wins. Here’s what this move co...
ZoomInfo Grew Revenue Just 1.5% Amid $17M Share Selloff
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
This Life Sciences Supplier Plunges 50% as Fund Buys Stock
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...